These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17022688)

  • 21. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
    Yamada H; Shinmura K; Okudela K; Goto M; Suzuki M; Kuriki K; Tsuneyoshi T; Sugimura H
    Carcinogenesis; 2007 Sep; 28(9):2013-8. PubMed ID: 17690113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of ANKRD11 as a p53 coactivator.
    Neilsen PM; Cheney KM; Li CW; Chen JD; Cawrse JE; Schulz RB; Powell JA; Kumar R; Callen DF
    J Cell Sci; 2008 Nov; 121(Pt 21):3541-52. PubMed ID: 18840648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
    Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
    Pietrzak M; Puzianowska-Kuznicka M
    Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression.
    Bitomsky N; Wethkamp N; Marikkannu R; Klempnauer KH
    Oncogene; 2008 Aug; 27(35):4820-9. PubMed ID: 18427550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sorting out metagenomes.
    Handelsman J
    Nat Biotechnol; 2005 Jan; 23(1):38-9. PubMed ID: 15637617
    [No Abstract]   [Full Text] [Related]  

  • 28. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
    Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-4 gene transcription in human T cells is suppressed by T-bet.
    Kitamura N; Kitamura F; Kaminuma O; Miyatake S; Tatsumi H; Nemoto S; Mori A
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():68-70. PubMed ID: 17541280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of beta-lactamase as a highly versatile genetic reporter for eukaryotic cells.
    Moore JT; Davis ST; Dev IK
    Anal Biochem; 1997 May; 247(2):203-9. PubMed ID: 9177678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
    Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
    Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directed evolution of p53 variants with altered DNA-binding specificities by in vitro compartmentalization.
    Fen CX; Coomber DW; Lane DP; Ghadessy FJ
    J Mol Biol; 2007 Aug; 371(5):1238-48. PubMed ID: 17610896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
    Kamihira S; Terada C; Sasaki D; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y
    Eur J Haematol; 2009 Apr; 82(4):301-7. PubMed ID: 19220422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable expression of a heterogeneous gene introduced via gene targeting into the HPRT locus of human fibrosarcoma cells.
    Koyama Y; Banzai T; Sonezaki S; Kusano K
    Biotechnol Bioeng; 2006 Dec; 95(6):1052-60. PubMed ID: 16807926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 controls hPar1 function and expression.
    Salah Z; Haupt S; Maoz M; Baraz L; Rotter V; Peretz T; Haupt Y; Bar-Shavit R
    Oncogene; 2008 Nov; 27(54):6866-74. PubMed ID: 18820708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid, single-tube method for quantitative preparation and analysis of RNA and DNA in samples as small as one cell.
    Hartshorn C; Anshelevich A; Wangh LJ
    BMC Biotechnol; 2005 Jan; 5():2. PubMed ID: 15649321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression analysis using quantitative reverse transcription-polymerase chain reaction and a multispecific internal control.
    Shire D; Legoux P
    Methods Mol Biol; 2000; 137():59-73. PubMed ID: 10948526
    [No Abstract]   [Full Text] [Related]  

  • 39. A new method of competitive reverse transcription polymerase chain reaction with SYBR Gold staining for quantitative analysis of mRNA.
    Oba R; Kudo Y; Sato N; Noda R; Otsuka Y
    Electrophoresis; 2006 Jul; 27(14):2865-8. PubMed ID: 16688698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for using direct injection of plasmid DNA to study cis-regulatory element activity in F0 Xenopus embryos and tadpoles.
    Wang C; Szaro BG
    Dev Biol; 2015 Feb; 398(1):11-23. PubMed ID: 25448690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.